Composition for enteral administration, process to improve physical strength or athletic performance of a mammal, to increase the concentration of protein, fat-free body mass or muscle mass in a mammalian, to decrease deposition of body fat for a given calorie intake and to increase fat loss body in a mammalian, to treat the catabolic effects o f disease in a mammalian, to improve the physical resistance or athletic performance of a mammalian, and to increase the mass of a lean meat body of a mammalian and decrease fat deposition

摘要

Composition for enteral administration, process to improve the resistance fu00ecsica or athletic performance of a mamu00ecfero, to increase the concentration of proteu00ecna,Body weight without fat or muscle mass in a mamu00ecfero, to decrease the deposition of fat in the body for a given caloric intake and increase the loss of body fat in a mamu00ecfero,To deal with the effects of the disease in a catabolic mamu00ecfero, for improving the resistance fu00ecsica or athletic performance of a mamu00ecfero, and.In order to increase the mass of a body of lean meat of a mamu00ecfero and decrease fat deposition ", the present invention is based, in part,The discovery that the use of pyruvate in combination with a cortisol blocker, such as phosphatidylserine, produces a synergistic effect in increasing body weight without fat or muscle tissue.Decreasing fat deposition, increasing strength and athletic performance of a mammal consuming the same.The invention also relates to a process for treating the catabolic effects of diseases such as cancer and AIDS by administration of pyruvate and a cortisol blocker.The present invention also describes a synergistic composition comprising pyruvate and a cortisol blocker.More specifically, the present invention relates to a composition comprising pyruvate and / or derived from pyruvate and phosphatidylserine.